Found: 22
Select item for more details and to access through your institution.
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05295-z
- By:
- Publication type:
- Article
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2302, doi. 10.3390/ijms25042302
- By:
- Publication type:
- Article
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9612, doi. 10.3390/ijms23179612
- By:
- Publication type:
- Article
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 4, p. 1, doi. 10.1007/s00018-022-04215-3
- By:
- Publication type:
- Article
Targeting CK2 in cancer: a valuable strategy or a waste of time?
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00717-4
- By:
- Publication type:
- Article
Protein kinase CK2: a potential therapeutic target for diverse human diseases.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00567-7
- By:
- Publication type:
- Article
Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 181, doi. 10.3390/cells10010181
- By:
- Publication type:
- Article
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance.
- Published in:
- Cellular Oncology (2211-3428), 2020, v. 43, n. 6, p. 1003, doi. 10.1007/s13402-020-00566-w
- By:
- Publication type:
- Article
White Adipose Tissue Expansion in Multiple Symmetric Lipomatosis Is Associated with Upregulation of CK2, AKT and ERK1/2.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7933, doi. 10.3390/ijms21217933
- By:
- Publication type:
- Article
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227340
- By:
- Publication type:
- Article
Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 23, p. 5951, doi. 10.3390/ijms20235951
- By:
- Publication type:
- Article
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.
- Published in:
- Oncogenesis, 2019, v. 8, n. 11, p. 1, doi. 10.1038/s41389-019-0171-x
- By:
- Publication type:
- Article
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity.
- Published in:
- FASEB Journal, 2019, v. 33, n. 10, p. 10648, doi. 10.1096/fj.201801833RR
- By:
- Publication type:
- Article
Role of protein kinase CK2 in antitumor drug resistance.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1292-y
- By:
- Publication type:
- Article
A proteomics analysis of CK2β<sup>(−/−)</sup> C2C12 cells provides novel insights into the biological functions of the non‐catalytic β subunit.
- Published in:
- FEBS Journal, 2019, v. 286, n. 8, p. 1561, doi. 10.1111/febs.14799
- By:
- Publication type:
- Article
Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.
- Published in:
- Cellular & Molecular Life Sciences, 2018, v. 75, n. 11, p. 2011, doi. 10.1007/s00018-017-2705-8
- By:
- Publication type:
- Article
CK2 is a key regulator of SLC4A2-mediated Cl/HCO exchange in human airway epithelia.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2017, v. 469, n. 9, p. 1073, doi. 10.1007/s00424-017-1981-3
- By:
- Publication type:
- Article
Exploring the CK2 Paradox: Restless, Dangerous, Dispensable.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 1, p. 11, doi. 10.3390/ph10010011
- By:
- Publication type:
- Article
Generation and quantitative proteomics analysis of CK2α/α'<sup>(−/−)</sup> cells.
- Published in:
- Scientific Reports, 2017, p. 42409, doi. 10.1038/srep42409
- By:
- Publication type:
- Article
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: Biochemical evidence and therapeutic perspectives.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 6, p. 1103, doi. 10.1016/j.molonc.2013.08.006
- By:
- Publication type:
- Article
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049193
- By:
- Publication type:
- Article
Regulation of Serotonin Transport in Human Platelets by Tyrosine Kinase Syk.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2011, v. 27, n. 2, p. 139, doi. 10.1159/000325216
- By:
- Publication type:
- Article